Cargando…

The Gut Microbial Metabolite Trimethylamine N-Oxide is Linked to Specific Complications of Systemic Sclerosis

BACKGROUND: Systemic sclerosis (SSc) is a rare immune-mediated connective tissue disease characterized by fibrosis of the skin and internal organs, whose pathogenesis is not fully understood. Recent studies have revealed dysbiosis in patients with systemic sclerosis and have indicated the possible r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stec, Albert, Maciejewska, Magdalena, Paralusz-Stec, Karolina, Michalska, Milena, Giebułtowicz, Joanna, Rudnicka, Lidia, Sikora, Mariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162098/ https://www.ncbi.nlm.nih.gov/pubmed/37152867 http://dx.doi.org/10.2147/JIR.S409489

Ejemplares similares

Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases
por: Stec, Albert, et al.
Publicado: (2023)

The Clinical Significance of Serum Biomarkers of the Intestinal Barrier in Systemic Sclerosis: A Cross-Sectional Study
por: Stec, Albert, et al.
Publicado: (2023)

Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study
por: Sikora, Mariusz, et al.
Publicado: (2021)

Copeptin as a Biomarker of Microcirculation Alterations in Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2023)

Hypoxia-Inducible Factor-1α (HIF-1α) as a Biomarker for Changes in Microcirculation in Individuals with Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2023)

Clinical Implications of Intestinal Barrier Damage in Psoriasis
por: Sikora, Mariusz, et al.
Publicado: (2021)

Gut Microbiome in Psoriasis: An Updated Review
por: Sikora, Mariusz, et al.
Publicado: (2020)

Raynaud’s Phenomenon with Focus on Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2022)

Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis
por: Sikora, Mariusz, et al.
Publicado: (2019)

Future Treatment Options in Systemic Sclerosis—Potential Targets and Ongoing Clinical Trials
por: Bohdziewicz, Anna, et al.
Publicado: (2022)

The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
por: Zhen, Jing, et al.
Publicado: (2023)

The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid
por: Rio, Daniele Del, et al.
Publicado: (2017)

Rapid Detection of Gut Microbial Metabolite Trimethylamine N-Oxide for Chronic Kidney Disease Prevention
por: Chang, Yu-Chun, et al.
Publicado: (2021)

The gut microbial-derived metabolite trimethylamine N-oxide: A missing link between lifestyle-components and atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2020)

The Gut Microbial-Derived Metabolite Trimethylamine N-Oxide and Atrial Fibrillation: Relationships, Mechanisms, and Therapeutic Strategies
por: Huang, Rui, et al.
Publicado: (2021)

The Clinical Significance of Salusins in Systemic Sclerosis—A Cross-Sectional Study
por: Nowaczyk, Joanna, et al.
Publicado: (2023)

The Microbial Metabolite Trimethylamine N-Oxide Links Vascular Dysfunctions and the Autoimmune Disease Rheumatoid Arthritis
por: Chan, Marion M., et al.
Publicado: (2019)

Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
por: Nowaczyk, Joanna, et al.
Publicado: (2020)

Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
por: Wang, BingYu, et al.
Publicado: (2021)

Facile Fluorescence Monitoring of Gut Microbial Metabolite Trimethylamine N-oxide via Molecular Recognition of Guanidinium-Modified Calixarene
por: Yu, Huijuan, et al.
Publicado: (2019)

The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
por: Vogt, Nicholas M., et al.
Publicado: (2018)

Elevation of the Gut Microbiota Metabolite Trimethylamine N-Oxide Predicts Stroke Outcome
por: Nam, Hyo Suk, et al.
Publicado: (2019)

Gut Microbial Signatures of Distinct Trimethylamine N-Oxide Response to Raspberry Consumption
por: Franck, Maximilien, et al.
Publicado: (2022)

Gut Biofactory—Neurocompetent Metabolites within the Gastrointestinal Tract. A Scoping Review
por: Skonieczna-Żydecka, Karolina, et al.
Publicado: (2020)

Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke
por: Sun, Taoping, et al.
Publicado: (2021)

Gut microbiota-derived metabolite trimethylamine-N-oxide and stroke outcome: a systematic review
por: Zhang, Peng, et al.
Publicado: (2023)

A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat
por: Xu, Rong, et al.
Publicado: (2015)

Intestinal Flora Metabolite Trimethylamine Oxide Is Inextricably Linked to Coronary Heart Disease
por: Zhang, Honghong, et al.
Publicado: (2022)

Changes in urinary metabolome related to body fat involve intermediates of choline processing by gut microbiota
por: Stec, Donald F., et al.
Publicado: (2019)

Heart Failure Disturbs Gut–Blood Barrier and Increases Plasma Trimethylamine, a Toxic Bacterial Metabolite
por: Drapala, Adrian, et al.
Publicado: (2020)

Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation
por: Kim, Seok-Jo, et al.
Publicado: (2022)

Gut microbial trimethylamine is elevated in alcohol-associated hepatitis and contributes to ethanol-induced liver injury in mice
por: Helsley, Robert N, et al.
Publicado: (2022)

Mechanisms linking gut microbial metabolites to insulin resistance
por: Jang, Hye Rim, et al.
Publicado: (2021)

Trimethylamine N-Oxide, a Gut Microbiota-Dependent Metabolite, is Associated with Frailty in Older Adults with Cardiovascular Disease
por: He, Wei, et al.
Publicado: (2020)

Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics
por: Shanmugham, Meyammai, et al.
Publicado: (2023)

Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults
por: Fretts, Amanda M., et al.
Publicado: (2022)

The role of adipokines in systemic sclerosis: a missing link?
por: Żółkiewicz, Jakub, et al.
Publicado: (2019)

Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota
por: Hoyles, Lesley, et al.
Publicado: (2018)

Uncovering the trimethylamine-producing bacteria of the human gut microbiota
por: Rath, Silke, et al.
Publicado: (2017)

Gut microbiota in atherosclerosis: focus on trimethylamine N‐oxide
por: Zhu, Yingqian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_smatla7dds5vd65jbo8m7n500g